E-LIB Suche - Ergebnisse für: Resteghini, C.

1

Late toxicities burden in patients with radioiodine-refract..:

Platini, F. ; Cavalieri, S. ; Alfieri, S....
Endocrine. 73 (2021) 3 - p. 641-647 , 2021

Link: https://doi.org/10.1007/..

2

PH-0043: Age related toxicity and outcome in oropharyngeal ..:

IvaldI, E. ; Infante, G. ; Facchinetti, N....
Radiotherapy and Oncology. 152 (2020) - p. S13-S14 , 2020

Link: https://doi.org/10.1016/..

3

PO-161 Mutational profile of epithelial, non-glandular sino..:

De Cecco, L. ; Serafini, M.S. ; Canevari, S....
Radiotherapy and Oncology. 132 (2019) - p. 85-86 , 2019

Link: https://doi.org/10.1016/..

4

PO-115 Radiomics-based prediction of response to induction ..:

Bologna, M. ; Calareso, G. ; Resteghini, C....
Radiotherapy and Oncology. 132 (2019) - p. 59 , 2019

Link: https://doi.org/10.1016/..

5

PO-165 Phase 2 study on axitinib in recurrent/metastatic sa..:

Locati, L.D. ; Cavalieri, S. ; Bergamini, C....
Radiotherapy and Oncology. 132 (2019) - p. 87-88 , 2019

Link: https://doi.org/10.1016/..

6

Efficacy and safety of single-agent pan-human epidermal gro..:

Cavalieri, S. ; Perrone, F. ; Miceli, R....
European Journal of Cancer. 97 (2018) - p. 7-15 , 2018

Link: https://doi.org/10.1016/..

7

Management of tyrosine kinase inhibitors (TKI) side effects..:

Resteghini, C. ; Cavalieri, S. ; Galbiati, D....
Best Practice & Research Clinical Endocrinology & Metabolism. 31 (2017) 3 - p. 349-361 , 2017

Link: https://doi.org/10.1016/..

8

Prognostic Value of Metabolic Parameters by 18 F-FDG PET/CT..:

Cavallo, A. ; Cicchetti, A. ; Iacovelli, N.A....
International Journal of Radiation Oncology*Biology*Physics. 99 (2017) 2 - p. S164-S165 , 2017

Link: https://doi.org/10.1016/..

9

PD-034: Subsite-dependent prognostic impact of age in patie..:

Orlandi, E. ; Infante, G. ; Granata, R....
Radiotherapy and Oncology. 122 (2017) - p. 20 , 2017

Link: https://doi.org/10.1016/..

10

Low etiologic fraction for human papillomavirus in larynx s..:

Taberna, M. ; Resteghini, C. ; Swanson, B....
Oral Oncology. 61 (2016) - p. 55-61 , 2016

Link: https://doi.org/10.1016/..

11

A phase II study of sorafenib in recurrent and/or metastati..:

Locati, L.D. ; Perrone, F. ; Cortelazzi, B....
European Journal of Cancer. 69 (2016) - p. 158-165 , 2016

Link: https://doi.org/10.1016/..

12

2865 Outcome of systemic treatments after first line platin..:

Siano, M. ; Resteghini, C. ; Cau, M.C....
European Journal of Cancer. 51 (2015) - p. S578 , 2015

Link: https://doi.org/10.1016/..

13

2827 Role of induction chemotherapy in the multimodal manag..:

Bossi, P. ; Pala, L. ; Orlandi, E....
European Journal of Cancer. 51 (2015) - p. S567 , 2015

Link: https://doi.org/10.1016/..

14

PO-092: Salivary Cytokine Levels and Mucositis in Head and ..:

Bossi, P. ; Filipazzi, P. ; Resteghini, C....
Radiotherapy and Oncology. 106 (2013) - p. S39 , 2013

Link: https://doi.org/10.1016/..

15

PO-113: Activity and Safety of Vinorelbine in Adenoid Cysti..:

Locati, L. ; Imbimbo, M. ; Bossi, P....
Radiotherapy and Oncology. 106 (2013) - p. S47-S48 , 2013

Link: https://doi.org/10.1016/..